Pembrolizumab: First Global Approval
Year: 2014
Type: review
Source: Drugs
Author: Raewyn M. Poole
Institution: Springer Nature (Germany)
Language: Indonesian
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2020684181
